IMNN · Imunon Inc
United States · RS rating 7 · As of 2026-11-03
| Price | 0.90 USD |
|---|---|
| 1-day change | +3.5% |
| RS rating (overall / 1M / 3M / 12M) | 7 / 14 / 12 / 9 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 2 / 39 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +35.7% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +79.5% |
| Market cap (USD) | $11.2M |